This seems like a remarkable comparison of products, with so much coming out in favour of BTM.
However, I wasn't sure what to make of the conclusion about economic differences. Seemed like it was a sales-driven article at first take. The authors did not state their postnominals, appointments or employers in the abstract title. Quite unusual in my experience/opinion.
However, a little digging has me much more reassured.
Timothy Olsen looks to be an MD candidate, doing a research paper: https://www.linkedin.com/in/timothy-olsen/
Derek Bell seems to be a senior in plastic and orthopaedic surgeries at Rochester: https://www.urmc.rochester.edu/surgery/plastic/team/
Safi Ali-Khan is listed as a resident physician at Rochester. https://www.linkedin.com/in/safi-ali-khan-a2bb61239/
If this is all genuine info, then it gives a lot more credibility to the abstract IMO.
bj.
The Clinicians Speak, page-863
-
- There are more pages in this discussion • 201 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.06 |
Change
0.010(0.49%) |
Mkt cap ! $1.422B | |||
| Open | High | Low | Value | Volume |
| $2.07 | $2.08 | $2.02 | $1.464M | 714.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 4237 | $2.06 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.07 | 15041 | 1 |
View Market Depth
| Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
| PNV (ASX) Chart |